Prophylactic use of tranexamic acid for reducing postpartum hemorrhage in vaginal delivery


  • Anusha Ginjupalli Department of Obstetrics and Gynecology, District Hospital, Ballari, Karnataka, India
  • Anuradha S. N. Department of Obstetrics and Gynecology, J.J.M. Medical College and Hospital, Davanagere, Karnataka, India
  • Joshi Suyajna D. Department of Obstetrics and Gynecology, District Hospital, Ballari, Karnataka, India



Maternal morbidity, Normal labour, Postpartum hemorrhage, Tranexamic acid


Background: The use of anti-fibrinolytic therapy has potential to reduce obstetric blood loss due to profound changes that take place in the fibrinolytic system during normal childbirth. Objective was to evaluate the efficacy of tranexamic acid in reducing postpartum hemorrhage (PPH) during normal labour.

Methods: Patients who planned for normal delivery and fulfilling the inclusion criteria were recruited for the study. The pre-delivery parameters -pulse rate, blood pressure, Hb gm% and PCV% were measured for each patient. The study group received injection oxytocin (10 IU) and injection tranexamic acid (500 mg) slow intravenous route. The control group received injection oxytocin (10 IU) and placebo injection. Immediately after delivery of the anterior shoulder of the baby, when all the liquor was drained, Brasse-V drape is placed under the patient. Then the patient was given pre-weighed pads, which were weighed 2 hours post-partum. Final blood loss was calculated by combining amount of blood collected in the drape and blood absorbed by the pads.

Results: The total number of patients studied was 300- equally distributed in both the groups. There was a significant increase in the pulse rate and decrease in blood pressure in the control group compared to the study group. The post-delivery haemoglobin and haematocrit were significantly reduced in the control group. The blood loss was significantly low in the study group. The need for other uterotonics, blood transfusion, and duration of hospital stay, were significantly low in study group.

Conclusions: Tranexamic acid, when given prophylactically to the women with vaginal delivery who received prophylactic oxytocin, appears to reduce the blood loss effectively compared to placebo alone.

Author Biography

Anusha Ginjupalli, Department of Obstetrics and Gynecology, District Hospital, Ballari, Karnataka, India

Obstetrics and Gynecology

Senior Resident


Chaudhary M, Shah M, Makwana N. Placental cord drainage during third stage of labour: a randomized control trial at a tertiary care centre. Int J Reprod Contracept Obstet Gynecol. 2020;9(3):1143-7.

Calvert C, Thomas SL, Ronsmans C, Wagner KS, Adler AJ, Filippi V. Identifying regional variation in the prevalence of postpartum hemorrhage: a systematic review and meta-analysis. PLoS One. 2012;7(7):e41114.

Trends in maternal mortality: 2000 to 2017: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. Geneva: World Health Organization; 2019.

Maswime S, Buchmann E. A systematic review of maternal near miss and mortality due to postpartum hemorrhage. Int J Gynaecol Obstet. 2017;137(1):1-7.

WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva: World Health Organization; 2012. Available from: Accessed on 5 November 2018.

Begley CM, Gyte GM, Devane D, Mc-Guire W, Weeks A. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev. 2015;3:CD007412.

Sentilhes L, Merlot B, Madar H, Sztark F, Brun S, Deneux-Tharaux C, et al. Postpartum haemorrhage: prevention and treatment. Expert Rev Hematol. 2016;9:1043-61.

Coviello EM, Grantz KL, Huang C, Kelly TE, Landy HJ. Risk factors for retained placenta. Am J Obstet Gynecol. 2015;213:864.e1-11.

WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with postpartum haemorrhage (WOMAN): an international, randomized, double blind, placebo controlled trial. Lancet. 2017;389:2105-16.

Prata N, Bell S, Weidert K. Prevention of postpartum hemorrhage in low-resource settings: current perspectives. Int J Wom Health. 2013;5:737-52.

Matsuzaki S, Jitsumori M, Hara T, Matsuzaki S, Nakagawa S, Miyake T, et al. Systematic review on the needle and suture types for uterine compression sutures: a literature review. BMC Surg. 2019;19:196.

Miller AD, Oner C, Kosik ES, McCalla S. Obstetric hemorrhage current management and usefulness of protocols, checklist, drills. Curr Obstet Gynecol Rep. 2016;5:355-64.

Sentilhes L, Lasocki S, Ducloy-Bouthors AS, Dreyfus M, Perrotin F, Goffinet F, et al. Tranexamic acid for the prevention and treatment of postpartum haemorrhage. Br J Anaesth. 2015;114:576-87.

Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;344:e3054.

Myles PS, Smith JA, Forbes A. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med. 2017;376:136-48.

Gai MY, Wu LF, Su QF, Tatsumoto K. Clinical observation of blood loss reduced by tranexamic acid during and after caesarean section: a multi center randomized trial. Eur J Obstet Gynecol Reprod Biol. 2004;112(2):154-7.

Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I, et al. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. Lancet. 2018;391(10116):125-32.

Yang H, Zheng S, Shi C. Clinical study on the efficiency of tranexamic acid in reducing postpartum blood loss- a randomized multicentre trial. Zhonghua Fu Chan Zazhi. 2001;36(10):590-2.

Matsunaga S, Takai Y, Seki H. Fibrinogen for the management of critical obstetric hemorrhage. J Obstet Gynaecol Res. 2019;45(1):13-21.

Peitsidis P, Kadir RA. Tranexamic acid in pregnancy and postpartum. Expert Opin Pharmacother. 2011;12(4):503-16.

Leduc D, Senikas V. Active management of third stage of labour: prevention and treatment of PPH. J Obstet Gynaecol Can. 2009;31(10):980-93.

Updated WHO Recommendation on Tranexamic Acid for the Treatment of Postpartum Haemorrhage. Geneva: World Health Organization; 2017.

The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next? BJOG. 2015:122(2):202-10.

Anderson JM, Etches D. Prevention and management of postpartum hemorrhage. Am Fam Phys. 2007;75(6):875-82.

Novikova N, Hofmeyr GJ. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2010;(7):CD007872.

Roy P, Sujatha MS, Bhandiwad A, Biswas B. Role of tranexamic acid in reducing blood loss in vaginal delivery. J Obstet Gynaecol India. 2016;66(1):246-50

Soltani H, Hutchon DR. Timing of prophylactic uterotonics for third stage of labour after vaginal birth. Cochrane Database Syst Rev. 2010;4(8):CD006173.

Tesseir V, Pierre F. Risk of PPH during labour and clinical and pharmacological prevention. J Obstet Gynaecol. 2004;33:4529-56.

Sentilhes L, Winer N, Azria E, Sénat MV, Le Ray C, Vardon D, et al. Tranexamic acid for the prevention of blood loss after vaginal delivery. N Engl J Med. 2018;379(8):731-42.

Sekhavat L, Tabatabaii A. Efficacy of tranexamic acid in reducing blood loss after caesarean section. J Matern Fet Neonat Med. 2009;22(1):72-5.

Litch JA. Program for appropriate technology and health. Seattle: AMTSL; 2004:132.

Gokhan. Routine practice of using tranexamic acid in AMTSL. NCT01338454, Bakirkoy; 2011.

Zargar M, Nikbakht R, Ahmadi M. The effect of tranexamic acid on preventing post-partum hemorrhage due to uterine atony: a triple-blind randomized clinical trial. Curr Clin Pharmacol. 2018;13:136-9.






Original Research Articles